Dicerna to Announce Fourth Quarter 2013 Financial Results and Host Conference Call on March 27, 2014

[at noodls] – WATERTOWN, Mass.–(BUSINESS WIRE)– Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, will report its fourth quarter 2013 financial results on March … more

View todays social media effects on DRNA

View the latest stocks trending across Twitter. Click to view dashboard

See who Dicerna is hiring next, click here to view